Jul 29, 2026 10:40PM
Jul 7, 2026 08:03AM
Jul 7, 2026 08:00AM
Mar 24, 2026 05:58PM
Nov 14, 2025 05:23PM
Oct 2, 2025 03:14PM
Sep 30, 2025 08:00AM Daxor Unveils New FDA-Cleared BVA Analyzer Amid Strong Market Demand and Pivotal Clinical Data at HFSA
Sep 23, 2025 08:04AM
Sep 23, 2025 08:00AM
Aug 7, 2025 07:58AM
Aug 7, 2025 07:55AM
May 14, 2025 08:00AM
Apr 15, 2025 08:00AM
Apr 2, 2025 08:02AM Daxor Corp. (DXR) Announces New Data from Duke University and Highlights Key BVA Insights at American College of Cardiology’s 74th Annual Scientific Session and Expo
Apr 2, 2025 08:00AM
Feb 19, 2025 08:03AM
Feb 19, 2025 08:00AM
Feb 14, 2025 08:00AM
Feb 14, 2025 08:00AM
Dec 18, 2024 08:00AM
Sep 27, 2024 05:00PM Daxor Corporation Streamlines Regulatory Strategy for Groundbreaking Diagnostic Device
Sep 12, 2024 08:00AM
Sep 3, 2024 04:06PM
Sep 3, 2024 04:05PM
Jun 5, 2024 08:01AM
Jun 5, 2024 08:00AM
Nov 10, 2022 08:00AM
Nov 10, 2022 08:00AM Live Webinar by MedAxiom Features Best Practices Using Daxor’s Blood Volume Analysis (BVA-100®) to Improve Heart Failure Outcomes and Reduce Costs
Oct 3, 2022 09:00AM
Oct 3, 2022 09:00AM
Sep 14, 2021 08:30AM
Sep 14, 2021 08:30AM

73,202 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All